It is proved that IL-21 has the potential to impact many aspects of the immune-mediated inflammatory disorders15, for inflammatory bowel diseases, systemic lupus erythematosus, diabetes and rheumatoid arthritis. This evidence concerns the gene IL21 and diabetes mellitus.